Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
Evangelos TerposIoannis P TrougakosMaria GavriatopoulouIoannis PapassotiriouAimilia D SklirouIoannis Ntanasis-StathopoulosEleni-Dimitra PapanagnouDespina FotiouEfstathios KastritisMeletios- Athanasios DimopoulosPublished in: Blood (2021)